Your browser does not support script OncoImmunin Akira Komoriya Akira Komoriya, CEO Dr. Akira Komoriya B.S. (Chemistry) Franklin and Marshall College Ph.D. (Physical Chemistry) Duke University Postdoctoral Fellowships: NIADDK and NCI, NIH Research Associate: Johns Hopkins University Scientist and M...

Your browser does not support script OncoImmunin Patented Technologies The Objective: The Solution: Peptide substrates for proteases associated with apoptosis, cell-mediated cytotoxicity, autophagy, metastasis, inflammation, and viral infectivity. A new class of cell and tissue permeable fluorogeni...

Your browser does not support script OncoImmunin [Application Note 1] Fluorescence-time course of the elastase substrate reaction: Data were obtained in buffer- similar data were obtained using serum) Ask us about our evaluation of the available fluorescence microplate readers for large sample thro...

Your browser does not support script OncoImmunin Inflammation Detection A vast literature strongly supports pivotal roles for caspase 1 and IL1-beta in inflammation and ischemia. However, due to the lack of a leader sequence in IL1-beta, its real time detection in live systems, as well as the detec...

OncoImmunin OncoImmunin, Inc. Making Intracellular Environments Accessible to Analysis & Intervention Patented Technologies Apoptosis Drug Delivery Licensing and Screening Company Profile Cancer Metastasis Cellular Cytotoxicity Inflammation Information Viral Detection Ordering Using OncoImmunin...